Spearhead Capital Advisors, LLC Sarepta Therapeutics, Inc. Transaction History

Spearhead Capital Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$62.69 - $88.44 $3,134 - $4,422	-50 Reduced 1.51%	3,259 $244,000
Q1 2022 Apr 28, 2022	SELL	$63.15 - $90.42 $118,406 - $169,537	-1,875 Reduced 36.17%	3,309 $258,000
Q4 2021 Jan 25, 2022	BUY	$77.28 - $99.42 $4,018 - $5,169	52 Added 1.01%	5,184 $467,000
Q3 2021 Oct 27, 2021	SELL	$65.97 - $92.48 $1,781 - $2,496	-27 Reduced 0.52%	5,132 $475,000
Q2 2021 Aug 10, 2021	BUY	$69.38 - $86.75 $58,764 - $73,477	847 Added 19.64%	5,159 $401,000
Q1 2021 Apr 28, 2021	BUY	$72.25 - $168.95 $171,232 - $400,411	2,370 Added 122.04%	4,312 $321,000
Q4 2020 Feb 02, 2021	BUY	$125.56 - $178.74 $8,914 - $12,690	71 Added 3.79%	1,942 $331,000
Q3 2020 Oct 16, 2020	BUY	$127.12 - $172.34 $14,364 - $19,474	113 Added 6.43%	1,871 $263,000
Q2 2020 Jul 16, 2020	BUY	$93.0 - $171.7 $163,494 - $301,848	1,758 New	1,758 $282,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.